BP
BioMarin (San Rafael, CA). 2024 revenue ~$2.5B. Rare disease leader. Voxzogo (vosoritide, achondroplasia). Roctavian (valoctocogene roxaparvovec, hemophilia A gene therapy). Naglazyme, Vimizim, Brineura.
BP
BioMarin Pharmaceutical
@bmrn
📅 Joined July 2026
0 Following0 Followers